[
    [
        {
            "time": "",
            "original_text": "白，云，山，子，公，司，断，货，中，标，药，品，天，心，制，药，或，遭，纳，入，全，国，“，黑，名，单，”，违，约，失，信",
            "features": {
                "keywords": [
                    "白云山",
                    "子公司",
                    "断货",
                    "中标药品",
                    "天心制药",
                    "黑名单",
                    "违约失信"
                ],
                "sentiment_score": -0.75,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "白，云，山，子，公，司，断，货，中，标，药，品，天，心，制，药，或，遭，纳，入，全，国，“，黑，名，单，”，违，约，失，信",
                "Correlation": 7,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        }
    ]
]